How Cannabis Businesses Get Started When They Have No Money? Ask Judy Rinkus at the Cannabis Capital Conference in September


The Benzinga Conference on the Cannabis Capital (CCC) arrives in the great city of Chicago on September 13-14, 2022.

As part of our lineup of amazing speakers, we are happy to have Judy Rinkusfounder and CEO of Seed To Sale Funding (STSF), which was founded in Michigan in 2019. Rinkus’ entrepreneurial expertise, which she will kindly share, includes being the director of STSF, a managing director of Bank of America, PNC Bank and Huntington Bank. During her banking career, Rinkus has focused on commercial loans ranging from $1.0 million to $100 million across a variety of industries. A graduate of the University of Michigan’s Ross School of Business, Rinkus also served as chief executive of Amherst Capital – a boutique firm in M&A, restructuring and consulting.

“I spent 30 years in the commercial lending departments of major banks. I left the banking industry almost 2 years ago. I was tired of working for The Man, literally since most of my managers were men,” Rinkus said. said. “I spent time finding an industry where I could leverage my financial skills, my business development skills, and my vast network of business professionals.”

Seed-to-Sale Financing: A Leader in Cannabis Debt Financing

Sale Seed Funding Completed $70 million in transactions since 2019 and has writing loans in 43 US states. The STSF team boasts over 100 years of combined commercial lending experience.

“When recreational marijuana was legalized in Michigan, I started getting questions from business contacts about financing start-up marijuana businesses. As you probably know, banks don’t lend to these businesses. Thanks to a series of connections, I was able to identify a group of about 20 non-bank lenders who were interested in the Michigan market. And before I knew it, I had a pipeline!” Rinkus said in an interview.

Recently, Seed To Sale Funding completed an $11.8 million deal with Juva Life Inc. JUVAF – a cannabis-focused, consumer-oriented pharmaceutical research and development company. This allowed Juva Life to acquire its plant in Stockton, California, and to continue its clinical research on two new compounds.

“The primary purpose of the financing was to provide capital to complete the acquisition, valued at over $17 million, for a purchase price of $4 million. In addition, Juva plans to use the funds to continue its clinical research development programs on novel compounds Juva-019 and Juva-041, targeting the treatment of inflammation,” Rinkus said.
Join us at the Benzinga Cannabis Capital Conference where cannabis entrepreneurs like Judy Rinkus will gather at the historic Palmer House Hotel September 13 and 14 in Chicago.
Get your tickets HERE.

Image by Benzinga


Comments are closed.